First-Line Antihypertensive Therapy for Elderly Patients with Hyperlipidemia

Rationale for Thiazide-Like Diuretics

The American College of Cardiology recommends thiazide diuretics as first-line therapy for elderly patients (>65 years) with hypertension, demonstrating superior efficacy in preventing cardiovascular events and stroke in this age group 1
The presence of hyperlipidemia is not a contraindication to thiazide therapy, and comprehensive cardiovascular risk reduction should include statin therapy given this patient's age and lipid disorder 2, 1

If thiazide diuretics cannot be used, a dihydropyridine calcium channel blocker (amlodipine 5-10 mg daily) is the preferred alternative for patients over 55 years of age 3, 1
ACE inhibitors or ARBs (such as lisinopril or losartan) are reasonable alternatives if diuretics and calcium channel blockers are contraindicated, though they are generally recommended for younger patients (<55 years) as initial monotherapy 3, 1

Add statin therapy for primary prevention given this patient's age (74 years), hypertension, and hyperlipidemia, as recommended for patients with 10-year coronary heart disease risk >30% 2

Start with chlorthalidone 12.5 mg daily or indapamide 1.25 mg daily, using lower initial doses in elderly patients and titrating gradually 1
Monitor electrolytes and renal function 1-2 weeks after initiation, checking for hypokalemia, hyperuricemia, and glucose intolerance 4, 5
Reassess blood pressure within 4-6 weeks, with a target of <140/90 mmHg (or <130/80 mmHg if tolerated without orthostatic hypotension) 5, 1
If blood pressure remains uncontrolled after 4-6 weeks, add a calcium channel blocker (amlodipine) or increase thiazide dose to 25 mg daily before considering triple therapy 4, 1

Check for orthostatic hypotension at each visit, as elderly patients are at higher risk for falls and postural symptoms 1
Monitor potassium levels closely, particularly if combining with ACE inhibitors or ARBs later, as potassium >5.5 mmol/L requires dose reduction 5
Achieve target blood pressure control within 3 months of initiating therapy, not 6-12 months, to maximize cardiovascular risk reduction 5
Use once-daily dosing and consider single-pill combinations to improve adherence in this elderly patient 1